This morning, Peter Glynn led us on a discussion on high-value care for abnormal LFTs. One study looked at the cost-effectiveness of focused testing (testing that is deliberate, patient-centered) compared with extensive, non-directed testing (testing for all etiologies at once). Some take-aways: When accounting for pre-test probabilities and clinical evaluation, focused testing was more cost-effective,
Tag: High value care
Things We Do For No Reason (TWDFNR) Supplemental oxygen for normoxemic patients! Multiple studies have shown no benefit and potentially harm when administering oxygen routinely to patients whose SpO2 is >94-96% or in those with 88-92% but underlying risk of respiratory failure (eg COPD patients) Do NOT give supplemental oxygen to acute MI patients unless